METHTARISC

Research group on Metabolism, Hypertension and Cardiovascular Risk

This group comprises physicians and econometrists of the Girona and Barcelona Health Regions with an interest in the study of the measurement of blood pressure, subclinical vascular disease associated with hypertension and the dynamic behaviour of cardiovascular risk factors. They collaborate with other investigators and networks within the IDIAP and other research bodies. The main objective of the group is to contribute information on 3 aspects of the role of blood pressure self-measurement (BPSM) with regard to the diagnosis of hypertension: 1.- Cut-off points of normality for the diagnosis of isolated clinical hypertension in relation to intermediate (evolution of subclinical vascular disease) and final variables (cardiovascular and renal morbidity and mortality ); 2.- Criteria for the diagnosis of isolated clinical hypertension or white coat hypertension; 3.- Optimal protocol for BPSM. The relationship between hypertension and subclinical vascular disease is concomitantly analysed. The research areas of this group are as follows: 1. Description of the normality cut-off points, the optimal protocol for measurement and diagnostic and prognostic value of BPSM; 2. Clinical validation of an automated screening of retinal microvasculature; 3. Assessment of the dynamic behaviour of metabolic syndrome and its components and cardiovascular morbidity and mortality; 4. Validation of specific cardiovascular risk tables for patients with Type 2 Diabetes.

Group projects

PI: Rodrigo Claverol, MDolores. Estudi d'efectivititat de la teràpia assistida amb animals (gossos) en població infantil amb transtorn per deficit atenció i hiperactivitat (TDAH). Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020

PI: Rodrigo Claverol, MDolores. Estimulació cognitiva assistida amb gossos en pacients amb deteriorament cognitiu: estudi d'efectivitat.. Funding: ICS - Institut Català de la Salut. Duration: 2017 - 2019

Group publications

PI: Coll de Tuero, Gabriel. Reproductibilitat de diversos protocols de mesura per determinar la diferència de pressió arterial entre braços en els pacients amb sospita d'Hipertensió Arterial (ARM-DIF Study). Funding: Fundació Catalana Hipertensio . Duration: 2017 - 2019

PI: Rodriguez Poncelas, Antonio. Asociación entre la administración de inhibidores de la bomba de protocones y la incidencia de enfermedad renal crónica y lesion renal aguda en población general. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019

PI: Mata Cases, José Manuel. Caracterización del riesgo cardiovascular antes del primer evento cardiovascular prematuro en Catalunya. Funding: Departament de Salut. Duration: 2017 - 2019

PI: Cerezo Goyeneche, Carlos. Ensayo híbrido de evaluación de una intervención compleja multiriesgo para promover conductas saludables en personas de 45-75 años atendidas en Atención Primaria: estudio EIRA3. Subproyecto Girona. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2019

PI: Coll de Tuero, Gabriel. Comportamiento dinámico del síndrome metabólico y elaboración de una ecuación para predecir el riesgo cardiovascular en los pacientes con Diabetes tipo 2 de una cohorte retrospectiva obtenida a partir de una base de datos clínico administrativa. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2018

The group participates in the following projects

PI: Bayó Llibre, Joan. Determinació dels valors de normalitat i de seguretat de l'automesura de la pressió arterial al domicili del pacient en el diagnòstic d' hipertensió arterial i del millor protocol de mesures d?aquesta tècnica. Funding: Fundació Academia Ciències Mediques de Catalunya i de Balears (L'Acadèmia). Duration: 2018

The group participates in the following publications

Benitez-Camps M, Morros Padrós R, Pera-Pujadas H, Dalfó Baqué A, Bayó Llibre J, Rebagliato Nadal O, Cortès Martinez J, García Sangenís A, Roca Saumell C, Coll de Tuero G, Vinyoles-Bargalló E; in representation of Paracetamol Investigators. Effect of effervescent paracetamol on blood pressure: a crossover randomized clinical trial. Journal of hypertension. 2018 Aug; 36(8):1656-1662. doi:10.1097/HJH.0000000000001733. PMID:29570512. IF: 4,085.

Dalfó-Pibernat A, Dalfó Baqué A, Pelegrina Rodríguez FJ, Garin O, Duran X, Cladellas Capdevila M, Comin Colet J. Improving ambulatory blood pressure monitoring knowledge in nurses and doctors: impact of a training intervention. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology. 2018 Jun; doi:10.1177/1474515118782100. Epub 2018 Jun 01. PMID:29873523. IF: 2,763.

Rodriguez A, Barrot J, Coll G, López C, Vlacho B, López F, Mundet X, Franch J. Glycaemic control and treatment of type 2 diabetes in adults aged 75 years or older. Int J Clin Pract. 2018;72(3):e13075. PMID:29512235. IF: 2,140.

Rodríguez-Poncelas A, Barceló MA, Saez M, Coll-de-Tuero G. Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort. PloS one. 2018 ; 13(10):e0204231. doi:10.1371/journal.pone.0204231. Epub 2018 Oct 17. PMID:30332411. IF: 2,806.

Rodriguez-Poncelas A, Coll-de-Tuero G, Blanch J, Comas-Cufí M, Saez M, Barceló MA. Prediabetes is associated with glomerular hyperfiltration in a European Mediterranean cohort study. Journal of nephrology. 2018 Oct; 31(5):743-749. doi:10.1007/s40620-018-0524-0. Epub 2018 Aug 27. PMID:30151699. IF: 2,153.

Indicators

Indicator

2018

Researchers with PhD

5

Total number of projects in which group members have participated

6

Total number of projects in which the PI of the project has belonged to the group

4

Total Funding

151.845,10€

Scientific publications in indexed journals

5

Total Impact factor

13,95

Nº of articles in Q1 journals

3

Q1 IF

9,654

Nº of articles in Q2 journals

2

Q2 IF

4,293

Anar a l'inici